首页> 外国专利> Devices and methods for inhibiting stenosis, occlusion or calcification of natural heart valves, stented heart valves or bioprostheses

Devices and methods for inhibiting stenosis, occlusion or calcification of natural heart valves, stented heart valves or bioprostheses

机译:用于抑制天然心脏瓣膜,带支架的心脏瓣膜或生物假体的狭窄,闭塞或钙化的装置和方法

摘要

The present invention relates to stenosis, occlusion or calcification of a valve of a natural valve that develops a disease via the Lrp5 / Wnt pathway after implantation of a valve prosthesis or in the presence of elevated lipid due to elevated low density lipoprotein. The present invention relates to a method for suppressing crystallization. The present invention involves administering a combination of medications to target inflammation and target cell attachment, and a second drug to inhibit proliferation and calcification on elastic stents, gortex grafts or valvular membranes. . Combination therapy suppresses bioprosthesis and natural valve calcification with improved life of artificial materials including stents, natural valves and gortex covers. The valve prosthesis and / or gortex implant is mounted on an elastic stent or prosthesis such that the elastic stent is connected to the valve.
机译:本发明涉及天然瓣膜的瓣膜狭窄,闭塞或钙化,该瓣膜在植入瓣膜假体之后或由于升高的低密度脂蛋白而存在升高的脂质的情况下经由Lrp5 / Wnt途径发展为疾病。本发明涉及一种抑制结晶的方法。本发明涉及施用用于靶向炎症和靶细胞附着的药物的组合,以及用于抑制在弹性支架,涡旋移植物或瓣膜上的增殖和钙化的第二种药物。 。组合疗法可抑制生物假体和天然瓣膜钙化,并延长人造材料的寿命,包括支架,天然瓣膜和顶盖。瓣膜假体和/或骨植入物安装在弹性支架或假体上,使得弹性支架连接到瓣膜。

著录项

  • 公开/公告号JP2018516624A

    专利类型

  • 公开/公告日2018-06-28

    原文格式PDF

  • 申请/专利权人 コンシーヴァルブ エルエルシー;

    申请/专利号JP20170553407

  • 发明设计人 ラジャマナン;ナリーニ エム.;

    申请日2016-04-15

  • 分类号A61F2/24;A61K39/395;A61P9;A61K45;A61K31/40;A61K31/366;A61K31/505;A61K31/47;A61K31/22;A61K31/473;A61K31/397;A61K31/519;A61K31/4365;A61K31/616;

  • 国家 JP

  • 入库时间 2022-08-21 13:10:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号